Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

Rafael Bejar, Allegra Lord, Kristen Stevenson, Michal Bar-Natan, Albert Pérez-Ladaga, Jacques Zaneveld, Hui Wang, Bennett Caughey, Petar Stojanov, Gad Getz, Guillermo Garcia-Manero, Hagop Kantarjian, Rui Chen, Richard M. Stone, Donna Neuberg, David P. Steensma, Benjamin L. Ebert, TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients Blood. ,vol. 124, pp. 2705- 2712 ,(2014) , 10.1182/BLOOD-2014-06-582809

F Traina, V Visconte, P Elson, A Tabarroki, A M Jankowska, E Hasrouni, Y Sugimoto, H Szpurka, H Makishima, C L O'Keefe, M A Sekeres, A S Advani, M Kalaycio, E A Copelan, Y Saunthararajah, S T Olalla Saad, J P Maciejewski, R V Tiu, Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia. ,vol. 28, pp. 78- 87 ,(2014) , 10.1038/LEU.2013.269

Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L. Ebert, Pierre Fenaux, Richard A. Larson, Ross L. Levine, Francesco Lo-Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Sanz, Jorge Sierra, Martin S. Tallman, Hwei-Fang Tien, Andrew H. Wei, Bob Löwenberg, Clara D. Bloomfield, Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Blood. ,vol. 129, pp. 424- 447 ,(2017) , 10.1182/BLOOD-2016-08-733196

Lars Bullinger, Konstanze Döhner, Hartmut Döhner, Genomics of Acute Myeloid Leukemia Diagnosis and Pathways Journal of Clinical Oncology. ,vol. 35, pp. 934- 946 ,(2017) , 10.1200/JCO.2016.71.2208

Ibrahim Aldoss, Dongyun Yang, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Monzr M. Al Malki, Matthew Mei, Amandeep Salhotra, Samer Khaled, Ryotaro Nakamura, David Snyder, Margaret O’Donnell, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat, Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia Haematologica. ,vol. 103, ,(2018) , 10.3324/HAEMATOL.2018.188094

Courtney D. DiNardo, Keith Pratz, Vinod Pullarkat, Brian A. Jonas, Martha Arellano, Pamela S. Becker, Olga Frankfurt, Marina Konopleva, Andrew H. Wei, Hagop M. Kantarjian, Tu Xu, Wan-Jen Hong, Brenda Chyla, Jalaja Potluri, Daniel A. Pollyea, Anthony Letai, Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. ,vol. 133, pp. 7- 17 ,(2019) , 10.1182/BLOOD-2018-08-868752